• Title/Summary/Keyword: Response criteria

검색결과 1,085건 처리시간 0.026초

Association of GSTP1 and RRM1 Polymorphisms with the Response and Toxicity of Gemcitabine-cisplatin Combination Chemotherapy in Chinese Patients with Non-small Cell Lung Cancer

  • Yuan, Zhi-Jun;Zhou, Wen-Wu;Liu, Wei;Wu, Bai-Ping;Zhao, Jin;Wu, Wei;He, Yi;Yang, Shuo;Su, Jing;Luo, Yi
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권10호
    • /
    • pp.4347-4351
    • /
    • 2015
  • Background: Previous studies showed that genetic polymorphisms of glutathione S-transferase P1 (GSTP1) were involved in glutathione metabolism and genetic polymorphisms of ribonucleotide reductase (RRM1) were correlated with DNA synthesis. Here we explored the effects of these polymorphisms on the chemosensitivity and clinical outcome in Chinese non-small cell lung cancer (NSCLC) patients treated with gemcitabine-cisplatin regimens. Materials and Methods: DNA sequencing was used to evaluate genetic polymorphisms of GSTP1 Ile105Val and RRM1 C37A-T524C in 47 NSCLC patients treated with gemcitabine-cisplatin regimens. Clinical response was evaluated according to RECIST criteria after 2 cycles of chemotherapy and toxicity was assessed by 1979 WHO criteria (acute and subacute toxicity graduation criteria in chemotherapeutic agents). Results: There was no statistical significance between sensitive and non-sensitive groups regarding the genotype frequency distribution of GSTP1 Ile105Val polymorphism (p>0.05). But for RRM1 C37A-T524C genotype, sensitive group had higher proportion of high effective genotype than non-sensitive group (p=0.009). And according to the joint detection of GSTP1 Ile105Val and RRM1 C37A-T524C polymorphisms, the proportion of type A (A/A + high effective genotype) was significantly higher in sensitive group than in non-sensitive group (p=0.009). Toxicity showed no correlation with the genotypes between two groups (p>0.05). Conclusions: Compared with single detection of genetic polymorphisms of GSTP1 Ile105Val or RRM1 C37A-T524C, joint detection of both may be more helpful for patients with NSCLC to receive gemcitabine-cisplatin regimens as the first-line chemotherapy. Especially, genetic polymorphism of RRM1 is more likely to be used as an important biomarker to predict the response and toxicity of gemcitabine-cisplatin combination chemotherapy in NSCLC.

Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma

  • Yu, Jeong Il;Yoo, Gyu Sang;Cho, Sungkoo;Jung, Sang Hoon;Han, Youngyih;Park, Seyjoon;Lee, Boram;Kang, Wonseok;Sinn, Dong Hyun;Paik, Yong-Han;Gwak, Geum-Youn;Choi, Moon Seok;Lee, Joon Hyeok;Koh, Kwang Cheol;Paik, Seung Woon;Park, Hee Chul
    • Radiation Oncology Journal
    • /
    • 제36권1호
    • /
    • pp.25-34
    • /
    • 2018
  • Purpose: This study aimed to evaluate the initial outcomes of proton beam therapy (PBT) for hepatocellular carcinoma (HCC) in terms of tumor response and safety. Materials and Methods: HCC patients who were not indicated for standard curative local modalities and who were treated with PBT at Samsung Medical Center from January 2016 to February 2017 were enrolled. Toxicity was scored using the Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Tumor response was evaluated using modified Response Evaluation Criteria in Solid Tumors (mRECIST). Results: A total of 101 HCC patients treated with PBT were included. Patients were treated with an equivalent dose of $62-92GyE_{10}$. Liver function status was not significantly affected after PBT. Greater than 80% of patients had Child-Pugh class A and albumin-bilirubin (ALBI) grade 1 up to 3-months after PBT. Of 78 patients followed for three months after PBT, infield complete and partial responses were achieved in 54 (69.2%) and 14 (17.9%) patients, respectively. Conclusion: PBT treatment of HCC patients showed a favorable infield complete response rate of 69.2% with acceptable acute toxicity. An additional follow-up study of these patients will be conducted.

Comparison of Efficacy and Toxicity of First Line Chemotherapy with or without Epirubicin for Patients with Advanced Stage Soft Tissue Sarcoma

  • Cao, Jie;Huang, Xin-En;Liu, Jin;Wu, Xue-Yan;Lu, Yan-Yan
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권12호
    • /
    • pp.7171-7177
    • /
    • 2013
  • Purpose: To compare the safety and efficacy of first-line chemotherapy regimen with or without doxorubicin in treating patients with advanced soft tissue sarcoma (STS). Patients and Methods: We retrospectively analyzed a cohort of 56 patients histologically confirmed with STS who were treated at Jiangsu Cancer Hospital and Research Institute from July 2011 to June 2012.The basic element of first line chemotherapy contained epirubicin in group B and lacked epirubicin in group A. Response was assessed using RECIST criteria. The Kaplan-Meier method was used to estimate progress free survival (PFS). Results: According to RECIST criteria, patients in group treated by chemotherapy without epirubicin, the objective response (OR) ratio was 6.5 % (CR0%+PR6.5%). Disease control rate (DCR=CR+PR+SD) was 25.8% with a median follow-up of 14.6 months, including 2 patients achieving a partial response (PR 6.5%) and a stable response (SD 19.4%) in 6. In group B with epirubicin based regimens, no patient had complete response, PR (28 %) was observed in 7 and SD (24 %) in 6. DCR was observed in 13 patients (52%). By Fisher's exact test, the DCR difference between the two groups was statistically significant (p=0.046). In group A, median PFS was 3.0 months (95%CI:2.1-3.8), compared with 4.0 months (95% CI:3.03-4.97) in group B (p=0.0397 by log-rank test). Epirubicin based chemotherapy and ECOG performance status 0-1 were identified as favorable factors for progression in our cohort of patients. Differences of nonhematologic and hematologic toxicities were not statistically significant between the two groups, and the addition of epirobicin was not associated with cardiac toxicity (p=0.446). Conclusion: Our study demonstrates that epirubicin-based chemotherapy is effective and well tolerated, and is superior to chemotherapy without epirubicin regarding efficacy. Therefore it is recommended that epirubicin-based chemotherapy should be considered as first line for patients with advanced STS.

원발성 폐암에서 냉동수술의 치료 효과 (Effects of Cryosurgery in Primary Lung Cancer)

  • 정원재;김광택;이은주;이성호;강문철;정재호;함수연;조성범
    • Journal of Chest Surgery
    • /
    • 제42권2호
    • /
    • pp.201-205
    • /
    • 2009
  • 배경: 2004년 11월 저자들이 국내에서는 처음으로 냉동치료를 시작한 이후 원발성 폐암에 대한 냉동수술의 국소 치료 효과를 분석하여 그 효과와 합병증 등을 분석하여 차후 냉동치료의 방향을 살펴보고자 하였다. 대상 및 방법: 2004년 11월부터 2007년 3월까지 17명의 환자를 대상으로 17개의 악성 폐종괴에 대한 냉동치료를 시행한 결과를 의무기록과 영상자료를 이용하여 후향적으로 분석하였다. 남자가 14명, 여자가 3명이었으며 연령은 중앙값이 64세(범위, $54{\sim}77$세)였다. 폐종괴의 평균 직경(장경)은 48.8mm (범위 ; $36{\sim}111mm$)였다. 추적 검사로써 흉부전산화단층촬영을 술 후 7일, 1개월, 3개월, 6개월에, 양전자단층촬영을 약 6개월에서 9개월 사이에 각각 시행하여, RECIST(Response Evaluation Criteria in Solid Tumors) 기준을 이용하여 분석하였다. 결과: 술후 6개월에 시행한 흥부전산화단층촬영 및 술후 6개월에서 9개월 사이에 시행한 양전자단층촬영을 기준으로 17명의 원발성 폐암 환자 중 6명(35.3%)은 완전관해를, 4명(23.5%)은 부분관해를, 3명(17.6%)은 무변화를, 4명(23.5%)은 진행성 병변을 보였다. 직경 4cm 이하의 10명의 원발성 폐암에서 5명(50.0%)은 완전관해를, 3명(30.0%)은 부분관해를, 2명(20.0%)은 무변화를 보였다. 4cm 이상의 경우는 부분관해 이상이 2명(11.8%), 무변화 및 진행성 병변이 5명(29.4%)로 통계상 뚜렷한 차이를 보였다($x^2$-test; p-value=0.034). 술후 합병증으로는 소량의 혈성객담이 1예에서 발생하였으나 술후 $1{\sim}2$일째 소실되었고 자연 소실된 피하기종이 1예 그리고 발열이 있었던 환자가 1명 있었다. 시술과 관련한 사망은 없었다. 냉동 치료 후 평균재원일수는 6.3일이었다. 결론: 이상의 연구 결과에서 원발성 폐암을 냉동수술로 치료할 경우 특히 장경의 평균이 4cm 이하인 종양에서 좋은 효과를 기대할 수 있다는 것을 알 수 있다. 냉동 수술이 비침습적이며 합병증이 경미하고 반복 치료가 가능하다는 점에서 수술 고위험 환자군의 폐암 치료에 중요한 역할을 할 수 있을 것으로 생각된다.

비소세포폐암 환자의 양전자방출 단층촬영에서 골수 대사활성도의 항암화학요법에 대한 반응 예측 (Association between Bone Marrow Hypermetabolism on 18F-Fluorodeoxyglucose Positron Emission Tomography and Response to Chemotherapy in Non-Small Cell Lung Cancer)

  • 설희윤;목정하;윤성훈;김지은;김기욱;박혜경;김성장;김윤성;이민기;박순규
    • Tuberculosis and Respiratory Diseases
    • /
    • 제66권1호
    • /
    • pp.20-26
    • /
    • 2009
  • 연구배경: 양전자방출 단층촬영은 최근 폐암의 진단과 병기 결정에 널리 사용된다. 본 연구에서는 비소세포폐암 환자에서 양전자방출 단층촬영에서의 골수 대사활성도의 증가가 항암화학요법에 대한 반응과 관련성이 있는지 알아보고자 하였다. 방 법: 조직학적으로 비소세포폐암으로 진단 받은 환자 중에 양전자 방출 단층촬영을 시행한 후 일차 항암화학 요법을 시행 받은 환자를 대상으로 하였다. 대상군의 양전자 방출 단층촬영상 골수 대사활성도는 요추 1, 2, 3번의 FDG 섭취를 측정하여 평가하였고, 항암화학요법에 대한 반응은 Response Evaluation Criteria in Solid Tumors (RECIST)를 이용하여 평가하였다. 결 과: 총 59명의 환자가 포함되었다. 대상군을 양전자 방출 단층촬영상 골수의 SUV가 1.37 이상인 군(21명, 35.6%)과 미만인 군(38명, 64.4%)으로 나누었고, 골수의 SUV와 간의 SUV의 비가 0.73 이상인 군(22명, 37.3%)과 미만인 군(37명, 62.7%)로 나누어 일차 항암화학요법에 대한 반응을 비교하였다. 골수의 SUV와 골수의 SUV와 간의 SUV의 비는 일차 항암화학요법에 대한 반응과 통계학적으로 유의한 차이가 없었다(p=0.142, 0.978). 결 론: 비소세포폐암 환자에서 양전자방출 단층촬영에서 나타난 골수 대사활성도는 항암화학요법에 대한 반응과 관련성이 없었다.

DYNAMICS OF A DELAY-DIFFUSION PREY-PREDATOR MODEL WITH DISEASE IN THE PREY

  • MUKHOPADHYAY B.;BHATTACHARYYA R.
    • Journal of applied mathematics & informatics
    • /
    • 제17권1_2_3호
    • /
    • pp.361-377
    • /
    • 2005
  • A mathematical model dealing with a prey-predator system with disease in the prey is considered. The functional response of the predator is governed by a Hoilling type-2 function. Mathematical analysis of the model regarding stability and persistence has been performed. The effect of delay and diffusion on the above system is studied. The role of diffusivity on stability and persistence criteria of the system has also been discussed.

유압용 파이롯트형 릴리프밸브의 시뮤레시숀 연구 (Digital Simulation of a Pilot-type Relief Valve)

  • 이정오;김현수
    • 대한기계학회논문집
    • /
    • 제3권3호
    • /
    • pp.104-115
    • /
    • 1979
  • The dynamic chracteristics of a two stage relief valve is studied theoretically and experimentally. The equations of motion of spools are derived and solved by digital compter simulation to find the stiability criteria.It is shown that the area of main spool head gives damping effect to the system and that the flow pressure-coefficient of the orifice in main spool is one of the most important parameters to determine stability and response. The experimental resuls are in good atreement with the theoretical results.

Sea Environmental Design Criteria for Coastal and Offshore Structures

  • Liu, Defu
    • 한국해안해양공학회:학술대회논문집
    • /
    • 한국해안해양공학회 1996년도 정기학술강연회 발표논문 초록집
    • /
    • pp.19-22
    • /
    • 1996
  • Extreme sea statistics and combinations of environmental events or response for structures are very important problem in performance evaluation and design of coastal and Offshore structures. A probabilistic method is developed that leads to the combination of Typhoon (Hurricane) or winter storm induces winds, waves, currents and surge for a generic site. The traditional recommendation for the fixed structures is a combination of the 100 years maximum wave height with the 100 years wind and current. (omitted)

  • PDF

다기준하(多基準下)의 혼성고체추진제 최적조성(混成固體推進劑 最適組成)에 관한 연구(硏究) (A Study on Optimal Composition for Composite Solid Propellant under Multiple Criteria)

  • 정병희;김기배
    • 산업공학
    • /
    • 제1권1호
    • /
    • pp.17-26
    • /
    • 1988
  • This paper describes a nonlinear goal programming approach to the optimal composition of composite solid propellant taking multiple characteristics into consideration synchronously. The nonlinear goal programming model with response functions, restrictions and the optimal value of each characteristic is developed using Scheffe's "Experiments with mixtures" and preference weighting system. Objective functions are described based on process, performance and assurance characteristics. The systematic approach to optimal composition in this study is proved efficient through a CTPB-AL-AP propellant which is one of composite solid propellant systems.

  • PDF

연속철근 콘크리트포장의 역학적거동 예측 기법연구 (A Study on Prediction Technique in Continously Reinforced Concrete Pavements)

  • 김연복
    • 한국전산구조공학회:학술대회논문집
    • /
    • 한국전산구조공학회 1991년도 봄 학술발표회 논문집
    • /
    • pp.68-71
    • /
    • 1991
  • In this study, to make a construction strategy to minimize or protect punchout and steel corrosion in CRCP, the following items have been studied; 1) Review of the structural response characteristics and the current design criteria in CRCP. 2) Evaluation of basic analytical concepts and the limit of application in the current models 3) Some suggestions of performance monitoring in CRCP and evaluation of construction s-trategy with preformed crack induces.

  • PDF